Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Coretherapix

Coretherapix
2006 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer of pharmaceutical products. The company engages in manufacturing of AlloCSC-01 and regenerative therapies to stimulate the endogenous repair of the heart, and to prevent the negative consequences of myocardial infarction.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
  • Santiago Grisolía, 2
  • Tres Cantos
  • 28760 Madrid
  • Spain

+34 918 00 00 00

Coretherapix Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Coretherapix‘s full profile, request access.

Request full access to PitchBook

Coretherapix Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Coretherapix‘s full profile, request access.

Request full access to PitchBook

Coretherapix Executive Team (3)

Name Title Board
Seat
Contact
Info
Lourdes Lapeña Chief Financial Officer
Juan Carlos del Castillo Tamayo Managing Director
Cristina Garmendia Mendizábal Chairwoman